Natixis’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,146
| Closed | -$254K | – | 1181 |
|
|
2022
Q1 | $254K | Buy |
+3,146
| New | +$254K | ﹤0.01% | 1082 |
|
|
2019
Q3 | – | Sell |
-2,792
| Closed | -$1.49M | – | 887 |
|
|
2019
Q2 | $1.49M | Buy |
2,792
+145
| +5% | +$77.4K | 0.01% | 484 |
|
|
2019
Q1 | $1.3M | Sell |
2,647
-749
| -22% | -$367K | 0.01% | 547 |
|
|
2018
Q4 | $1.67M | Buy |
3,396
+1,514
| +80% | +$746K | 0.01% | 446 |
|
|
2018
Q3 | $1.72M | Buy |
+1,882
| New | +$1.72M | 0.01% | 504 |
|
|
2018
Q1 | – | Sell |
-1,072
| Closed | -$960K | – | 946 |
|
|
2017
Q4 | $960K | Buy |
1,072
+287
| +37% | +$257K | 0.01% | 505 |
|
|
2017
Q3 | $283K | Buy |
+785
| New | +$283K | ﹤0.01% | 935 |
|
|
2017
Q2 | – | Sell |
-1,102
| Closed | -$388K | – | 940 |
|
|
2017
Q1 | $388K | Buy |
+1,102
| New | +$388K | ﹤0.01% | 590 |
|